Shalby Limited (SHALBY) - Net Assets
Based on the latest financial reports, Shalby Limited (SHALBY) has net assets worth Rs10.03 Billion INR (≈ $108.45 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs17.82 Billion ≈ $192.76 Million USD) and total liabilities (Rs7.80 Billion ≈ $84.31 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Shalby Limited to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs10.03 Billion |
| % of Total Assets | 56.26% |
| Annual Growth Rate | 20.38% |
| 5-Year Change | 19.25% |
| 10-Year Change | 349.01% |
| Growth Volatility | 44.99 |
Shalby Limited - Net Assets Trend (2012–2025)
This chart illustrates how Shalby Limited's net assets have evolved over time, based on quarterly financial data. Also explore how large is Shalby Limited's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Shalby Limited (2012–2025)
The table below shows the annual net assets of Shalby Limited from 2012 to 2025. For live valuation and market cap data, see market value of Shalby Limited.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs9.95 Billion ≈ $107.64 Million |
-1.24% |
| 2024-03-31 | Rs10.08 Billion ≈ $108.99 Million |
+8.64% |
| 2023-03-31 | Rs9.28 Billion ≈ $100.32 Million |
+5.87% |
| 2022-03-31 | Rs8.76 Billion ≈ $94.76 Million |
+4.97% |
| 2021-03-31 | Rs8.35 Billion ≈ $90.27 Million |
+4.44% |
| 2020-03-31 | Rs7.99 Billion ≈ $86.43 Million |
+2.49% |
| 2019-03-31 | Rs7.80 Billion ≈ $84.34 Million |
+2.41% |
| 2018-03-31 | Rs7.62 Billion ≈ $82.35 Million |
+176.43% |
| 2017-03-31 | Rs2.75 Billion ≈ $29.79 Million |
+24.27% |
| 2016-03-31 | Rs2.22 Billion ≈ $23.97 Million |
+29.81% |
| 2015-03-31 | Rs1.71 Billion ≈ $18.47 Million |
+19.08% |
| 2014-03-31 | Rs1.43 Billion ≈ $15.51 Million |
+35.63% |
| 2013-03-31 | Rs1.06 Billion ≈ $11.43 Million |
+18.40% |
| 2012-03-31 | Rs892.99 Million ≈ $9.66 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shalby Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 809.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs4.44 Billion | 44.74% |
| Common Stock | Rs1.07 Billion | 10.83% |
| Other Comprehensive Income | Rs20.07 Million | 0.20% |
| Other Components | Rs4.39 Billion | 44.22% |
| Total Equity | Rs9.92 Billion | 100.00% |
Shalby Limited Competitors by Market Cap
The table below lists competitors of Shalby Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Arise Windpower AB
ST:ARISE
|
$195.75 Million |
|
coocon Corp.
KQ:294570
|
$195.77 Million |
|
Zentalis Pharmaceuticals Llc
NASDAQ:ZNTL
|
$195.77 Million |
|
Stove Kraft Limited
NSE:STOVEKRAFT
|
$195.80 Million |
|
SNS
KLSE:0259
|
$195.64 Million |
|
Amway (Malaysia) Holdings Bhd
KLSE:6351
|
$195.63 Million |
|
Veritone Inc
NASDAQ:VERI
|
$195.55 Million |
|
Alarko Carrier Sanayi ve Ticaret AS
IS:ALCAR
|
$195.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shalby Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,003,740,000 to 9,921,880,000, a change of -81,860,000 (-0.8%).
- Net income of 62,220,000 contributed positively to equity growth.
- Dividend payments of 129,610,000 reduced retained earnings.
- Share repurchases of 750,000 reduced equity.
- New share issuances of 750,000 increased equity.
- Other comprehensive income decreased equity by 23,280,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs62.22 Million | +0.63% |
| Dividends Paid | Rs129.61 Million | -1.31% |
| Share Repurchases | Rs750.00K | -0.01% |
| Share Issuances | Rs750.00K | +0.01% |
| Other Comprehensive Income | Rs-23.28 Million | -0.23% |
| Other Changes | Rs8.81 Million | +0.09% |
| Total Change | Rs- | -0.82% |
Book Value vs Market Value Analysis
This analysis compares Shalby Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.82x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 21.63x to 1.82x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-03-31 | Rs7.80 | Rs168.60 | x |
| 2013-03-31 | Rs9.44 | Rs168.60 | x |
| 2014-03-31 | Rs13.04 | Rs168.60 | x |
| 2015-03-31 | Rs15.59 | Rs168.60 | x |
| 2016-03-31 | Rs20.49 | Rs168.60 | x |
| 2017-03-31 | Rs25.50 | Rs168.60 | x |
| 2018-03-31 | Rs80.70 | Rs168.60 | x |
| 2019-03-31 | Rs72.20 | Rs168.60 | x |
| 2020-03-31 | Rs73.99 | Rs168.60 | x |
| 2021-03-31 | Rs77.28 | Rs168.60 | x |
| 2022-03-31 | Rs81.13 | Rs168.60 | x |
| 2023-03-31 | Rs86.36 | Rs168.60 | x |
| 2024-03-31 | Rs92.45 | Rs168.60 | x |
| 2025-03-31 | Rs92.50 | Rs168.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shalby Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.63%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.57%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.72x
- Recent ROE (0.63%) is below the historical average (12.16%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 30.10% | 14.25% | 1.70x | 1.24x | Rs169.24 Million |
| 2013 | 16.78% | 7.60% | 1.48x | 1.49x | Rs69.11 Million |
| 2014 | 27.70% | 15.08% | 1.19x | 1.54x | Rs249.40 Million |
| 2015 | 15.28% | 9.34% | 0.78x | 2.09x | Rs88.90 Million |
| 2016 | 16.98% | 12.94% | 0.56x | 2.35x | Rs154.53 Million |
| 2017 | 22.72% | 19.23% | 0.45x | 2.61x | Rs350.21 Million |
| 2018 | 5.64% | 11.20% | 0.40x | 1.27x | Rs-332.21 Million |
| 2019 | 4.06% | 6.87% | 0.49x | 1.20x | Rs-463.18 Million |
| 2020 | 3.45% | 5.67% | 0.50x | 1.21x | Rs-523.30 Million |
| 2021 | 5.08% | 9.84% | 0.43x | 1.19x | Rs-410.69 Million |
| 2022 | 6.18% | 7.74% | 0.59x | 1.36x | Rs-335.07 Million |
| 2023 | 7.30% | 8.41% | 0.63x | 1.38x | Rs-250.68 Million |
| 2024 | 8.40% | 9.00% | 0.58x | 1.61x | Rs-159.60 Million |
| 2025 | 0.63% | 0.57% | 0.64x | 1.72x | Rs-929.97 Million |
Industry Comparison
This section compares Shalby Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $6,445,149,449
- Average return on equity (ROE) among peers: 5.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shalby Limited (SHALBY) | Rs10.03 Billion | 30.10% | 0.78x | $195.64 Million |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $13.33 Billion | 6.41% | 0.69x | $12.59 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $1.05 Billion | -3.17% | 1.52x | $4.15 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.18 Billion | 21.86% | 0.58x | $127.89 Million |
| Healthcare Global Enterprises Limited (HCG) | $8.84 Billion | 6.08% | 1.51x | $920.71 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.88 Billion | 17.73% | 2.15x | $885.77 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $-1.38 Billion | 0.00% | 0.00x | $3.11 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $151.10 Million | 8.52% | 0.57x | $26.18 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $11.28 Billion | -2.00% | 1.70x | $10.66 Billion |
| Max India Limited (MAXIND) | $13.94 Billion | -3.31% | 0.70x | $102.06 Million |
| Global Health Limited (MEDANTA) | $12.17 Billion | 2.70% | 0.63x | $3.49 Billion |
About Shalby Limited
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology servic… Read more